Completed FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors NCT03841110 Conditions Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more Locations UCSD Moores Cancer Center — San Diego, California, United States University of Minnesota Masonic Cancer Center — Minneapolis, Minnesota, United States Hackensack University Medical Center/John Theurer Cancer Center — Hackensack, New Jersey, United States MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Completed FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors NCT03319459 Conditions Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more Locations UCSD Moores Cancer Center — San Diego, California, United States University of Minnesota — Minneapolis, Minnesota, United States The Ohio State University James Cancer Hospital — Columbus, Ohio, United States Baylor Scott & White Research Institute — Dallas, Texas, United States View Trial Details
